- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03490721
Effects of Clustering Care on the Physiological Stability of Preterm Infants.
January 14, 2020 updated by: Abril Nicole Fernandez Oviedo, Université de Montréal
Effects of Clustering Care on the Physiological Stability of Preterm Infants in a Neonatal Intensive Care Unit.
This crossover design experimental study aims to compare the physiological stability of premature newborns during and after a cluster of care compared to a period when they receive standard non clustered care at the neonatal unit.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The cluster care will take place at the time of feeding of the premature infants.
The intervention will start with a calm period of 20 minutes before the start of care (no manipulations will be allowed), the baby will then received the cluster care for 20 minutes and a quiet period of 30 minutes will follow after the cluster care.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Montréal, Quebec, Canada, H3T1E2
- Jewish General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 months to 7 months (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- between 26 to 31 6/7 weeks of gestation at birth
- more than 72 hours of life,
- receive a respiratory aid such as endotracheal tube, NIPPV (non invasive positive pressures ventilation), CPAP (continuous positive airway pressure) or nasal prongs with oxygen,
- are fed intravenously (IV) or by central venous catheter (CVC),
- one of the parents speaks and reads English or French,
- one of the parents is at least 18 years old to sign the consent.
Exclusion Criteria:
- severely ill (necrotizing enterocolitis, septicemia),
- under respiratory assistance or on a high frequency mode,
- having a congenital or cardiac abnormality,
- requiring surgery,
- sedatives or opioids,
- diagnosed with grade II, III or IV intraventricular hemorrhage and / or hydrocephalus,
- have a device for invasive blood pressure,
- having an oxygen requirement of more than 30% to maintain oxygen saturation within the limits indicated by the NICU (neonatal intensive care unit).
- one of the parents is at least 18 years old to sign the consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Clustering care for 20 minutes.
|
During 20 minutes, preterm infants will receive a cluster care with 2 minutes of hand containment.
|
No Intervention: Control
Standard care non clustered.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physiological stability (heart rate, respiratory rate and oxygen saturation)
Time Frame: The physiological stability will be measured for 70 minutes.
|
The physiological stability will be measured with the SCRIP score.
The Stability of the cardiorespiratory system in premature infants is a scale, in which a score of 0 means major physiological instability and a score of 6 means a physiological stability.
For every single parameter there's three grades from severe instability (0 points) to minor instability (1 point) to perfect stability (2 points).
|
The physiological stability will be measured for 70 minutes.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Marilyn Aita, PhD, Université de Montréal
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 12, 2018
Primary Completion (Actual)
April 3, 2019
Study Completion (Actual)
May 30, 2019
Study Registration Dates
First Submitted
March 23, 2018
First Submitted That Met QC Criteria
April 5, 2018
First Posted (Actual)
April 6, 2018
Study Record Updates
Last Update Posted (Actual)
January 18, 2020
Last Update Submitted That Met QC Criteria
January 14, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- Etude_maitrise_2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
The results of this project could be made public in a journal or scientific congress.
IPD Sharing Time Frame
The results of the study will be available when the study is finished.
IPD Sharing Access Criteria
The results will be published in a scientific journal.
IPD Sharing Supporting Information Type
- Clinical Study Report (CSR)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Baby 26 to 32 Weeks
-
University Hospital, BordeauxRecruitingPremature Baby 26 to 32 Weeks | Premature Baby 33 to 36 WeeksFrance
-
University of PatrasUniversity Hospital of PatrasEnrolling by invitationPreterm Birth | Premature Baby 26 to 32 WeeksGreece
-
Nurgül TekinNot yet recruitingPain | Aspiration | Premature Baby 26 to 32 Weeks | Premature Baby 33 to 36 Weeks
-
Nurgül TekinNot yet recruitingPain | Retinopathy of Prematurity | Premature Baby 26 to 32 Weeks | Premature Baby 33 to 36 Weeks
-
University Hospital, ToursUnknownPremature Baby 25 to 32 WeeksFrance
-
Assistance Publique - Hôpitaux de ParisCompletedBronchopulmonary Dysplasia | Premature Baby 26 to 32 WeeksFrance
-
University of California, San FranciscoCompletedA Pilot Randomized Controlled Trial of the Effects of Daily Skin-to-skin Contact (PRCTS2S) (PRCTS2S)Oxidative Stress | Mother-Infant Interaction | Premature Baby 33 to 36 WeeksUnited States
-
Centre Hospitalier Universitaire DijonCompletedPremature Between 32 and 36 Weeks of AmenorrhoeaFrance
-
Centre Hospitalier Universitaire DijonRecruitingExtremely Premature Newborn (Born Before 32 Weeks' Gestation)France
-
Assistance Publique - Hôpitaux de ParisBlédina SA, Villefranche sur Saône, FranceCompletedPreterms With Gestational Age Ranging From 30 to 35 WeeksFrance
Clinical Trials on Clustering care
-
Centre Hospitalier Intercommunal de Toulon La Seyne...Centre Antoine LacassagneRecruiting
-
University Hospital, MontpellierCompletedObesity | Stress | AnxietyFrance
-
University Hospital, GhentRecruiting
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Maastricht University Medical CenterMaastricht UniversityCompleted
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenCompletedStroke | Frailty | Hip FracturesBelgium
-
Carlos III Health InstituteHealth Department of the Basque GovernmentCompleted
-
Evandro Chagas Institute of Clinical ResearchAlejandro Marcel Hasslocher Moreno, MD MSc PhD student; Andrea Costa, MD PhD; Andrea Silvestre de Sousa, MD PhD and other collaboratorsUnknownChagas Heart DiseaseBrazil
-
University of Lausanne HospitalsNational Heart, Lung, and Blood Institute (NHLBI); Swiss National Science FoundationCompletedPulmonary EmbolismSwitzerland, France, United States, Belgium
-
Johns Hopkins Bloomberg School of Public HealthRecruitingBreast CancerUnited States